Skip to main content

Articles

1215 result(s) for 'cancer' within Journal of Ovarian Research

Page 13 of 25

  1. Serous carcinoma, the subtype of ovarian cancer has the highest occurrence and mortality in ... in tissue s obtained from patients with ovarian cancer.

    Authors: Haniyeh Bashi zadeh fakhar, Hakimeh Zali, Mostafa Rezaie-Tavirani, Roya Faraji Darkhaneh and Babak Babaabasi
    Citation: Journal of Ovarian Research 2019 12:64
    Content type: Research Published on:

  2. Ovarian cancer is the major cause of death among gynecologic cancers with 75% of patients diagnosed with advanced...

    Authors: Maureen L. Drakes, Swati Mehrotra, Monica Aldulescu, Ronald K. Potkul, Yueying Liu, Anne Grisoli, Cara Joyce, Timothy E. O’Brien, M. Sharon Stack and Patrick J. Stiff
    Citation: Journal of Ovarian Research 2018 11:43
    Content type: Research Published on:

  3. We investigated plasma levels of M-CSF and conventional tumor markers (HE4 and CA 125) in epithelial ovarian cancer patients as compared to control groups: benign...

    Authors: Grażyna Ewa Będkowska, Sławomir Ławicki, Ewa Gacuta, Przemysław Pawłowski and Maciej Szmitkowski
    Citation: Journal of Ovarian Research 2015 8:27
    Content type: Research Published on:

  4. Elevated hyaluronan-mediated motility receptor (RHAMM) has been reported to contribute to disease progression, aggressive phenotype and poor prognosis in multiple cancer types, however, RHAMM’s role in ovarian cancer

    Authors: Stephanie T. Buttermore, Mitchel S. Hoffman, Ambuj Kumar, Anne Champeaux, Santo V. Nicosia and Patricia A. Kruk
    Citation: Journal of Ovarian Research 2017 10:66
    Content type: Research Published on:

  5. Luteolin, a polyphenolic flavone, has been demonstrated to exert anti-tumor activity in various cancer types. Cisplatin drug resistance is a major obstacle in the management of ovarian cancer. In the present stud...

    Authors: Haixia Wang, Youjun Luo, Tiankui Qiao, Zhaoxia Wu and Zhonghua Huang
    Citation: Journal of Ovarian Research 2018 11:93
    Content type: Research Published on:

  7. Virotherapy represents a promising approach for ovarian cancer. In this regard, conditionally replicative adenovirus...

    Authors: Rebeca González-Pastor, Ahmad Mohammad Ashshi, Adel Galal El-Shemi, Igor P. Dmitriev, Elena A. Kashentseva, Zhi Hong Lu, S. Peter Goedegebuure, Osvaldo L. Podhajcer and David T. Curiel
    Citation: Journal of Ovarian Research 2019 12:18
    Content type: Brief Communication Published on:

  10. The use of patient reported outcome measures (PROMs) has increased during the past decade, and the focus on how to use them has resulted in a more proactive application. Studies have shown that proactive use of P...

    Authors: Anette Stolberg Kargo, Angela Coulter, Pernille Tine Jensen and Karina Dahl Steffensen
    Citation: Journal of Ovarian Research 2019 12:63
    Content type: Review Published on:

  11. Ovarian cancer (OVC) is the deadliest of all gynecologic cancers, primarily as a consequence of asymptomatic progression...

    Authors: Ayala Tamir, Anju Gangadharan, Sakshi Balwani, Takemi Tanaka, Ushma Patel, Ahmed Hassan, Stephanie Benke, Agnieszka Agas, Joseph D’Agostino, Dayoung Shin, Sunghoon Yoon, Andre Goy, Andrew Pecora and K. Stephen Suh
    Citation: Journal of Ovarian Research 2016 9:20
    Content type: Research Published on:

  13. The purpose of this retrospective study was to determine the prognosis of non-serous epithelial ovarian cancer (EOC) patients with exclusively retroperitoneal lymph...

    Authors: Hanifi Sahin, Mehmet Mutlu Meydanli, Mustafa Erkan Sari, Ibrahim Yalcin, Gonca Çoban, Nazlı Topfedaisi Ozkan, Zeliha Firat Cuylan, Baki Erdem, Kemal Gungorduk, Özgür Akbayir, Murat Dede, Mustafa Coşkun Salman, Tayfun Güngör and Ali Ayhan
    Citation: Journal of Ovarian Research 2018 11:21
    Content type: Research Published on:

  14. While tumor suppressor p53 functions primarily as a transcription factor in the nucleus, cellular stress can cause p53 to translocate to the mitochondria and directly trigger a rapid apoptotic response. We have p...

    Authors: Phong Lu, Erica R. Vander Mause, Katherine E. Redd Bowman, Sarah M. Brown, Lisa Ahne and Carol S. Lim
    Citation: Journal of Ovarian Research 2019 12:45
    Content type: Research Published on:

  15. Ovarian cancer is the leading gynecologic cancer diagnosed in North America and because related ... state, and the need for chemotherapy. Ovarian cancer is frequently sensitive to chemotherapy at diagnosis...

    Authors: Taryne Chong, Amila Sarac, Cindy Q. Yao, Linda Liao, Nicola Lyttle, Paul C. Boutros, John M. S. Bartlett and Melanie Spears
    Citation: Journal of Ovarian Research 2018 11:27
    Content type: Research Published on:

  16. We have previously shown that a whole flaxseed supplemented diet decreased the onset and severity of ovarian cancer in the laying hen, the only known animal model of spontaneous ovarian cancer. Flaxseed is rich i...

    Authors: Purab Pal, Karen Hales, Jim Petrik and Dale Buchanan Hales
    Citation: Journal of Ovarian Research 2019 12:49
    Content type: Research Published on:

  17. Multiple drug resistance (MDR) of cancer cells is the main reason of intrinsic or acquired insensitivity to chemotherapy in many cancers. In this study we used ovarian cancer model of acquired drug resistance to ...

    Authors: Radosław Januchowski, Karolina Sterzyńska, Katarzyna Zaorska, Patrycja Sosińska, Andrzej Klejewski, Maciej Brązert, Michał Nowicki and Maciej Zabel
    Citation: Journal of Ovarian Research 2016 9:65
    Content type: Research Published on:

  18. Epithelial ovarian cancer (EOC) is usually diagnosed late at...BRCA status or homologous recombination (HR) deficiency. Several trials testing PARPi early in maintenance therapy are in progress and their results ...

    Authors: Sudeep Gupta, Shona Nag, Shyam Aggarwal, Amit Rauthan and Narayanankutty Warrier
    Citation: Journal of Ovarian Research 2019 12:103
    Content type: Review Published on:

  19. A high-quality risk prediction model is urgently needed for the clinical management of ovarian cancer. However most existing models are solely based ... factors (the synthetic model) for epithelial ovarian cancer

    Authors: Meiying Zhang, Guanglei Zhuang, Xiangjun Sun, Yanying Shen, Aimin Zhao and Wen Di
    Citation: Journal of Ovarian Research 2015 8:67
    Content type: Research Published on:

  20. B-cell-specific Moloney murine leukemia virus integration site 1 (BMI1) might be an appropriate biomarker in the management of epithelial ovarian cancer (EOC). However, the biological role...

    Authors: Qianying Zhao, Qiuhong Qian, Dongyan Cao, Jiaxin Yang, Ting Gui and Keng Shen
    Citation: Journal of Ovarian Research 2018 11:31
    Content type: Research Published on:

  21. Seven candidate drug-based molecular biomarkers, human epidermal growth factor receptor (EGFR), human epidermal growth factor receptor-2 (HER2), phosphatase and tensin homolog deleted on chromosome ten (PTEN), au...

    Authors: Mengjiao Li, Haoran Li, Fei Liu, Rui Bi, Xiaoyu Tu, Lihua Chen, Shuang Ye and Xi Cheng
    Citation: Journal of Ovarian Research 2017 10:9
    Content type: Research Published on:

  23. The purpose of this case-control study was to compare the prognoses of women with stage III mucinous ovarian carcinoma (MOC) who received maximal or optimal cytoreduction followed by paclitaxel plus carboplatin c...

    Authors: Zeliha Firat Cuylan, Emine Karabuk, Murat OZ, Ahmet Taner Turan, Mehmet M. Meydanli, Salih Taskin, Mustafa Erkan Sari, Hanifi Sahin, Suat C. Ulukent, Ozgur Akbayir, Kemal Gungorduk, Tayfun Gungor, Mehmet F. Kose and Ali Ayhan
    Citation: Journal of Ovarian Research 2018 11:91
    Content type: Research Published on:

  25. Autophagy is a conserved cellular self-digestion mechanism that can either suppress or promote cancer in a context-dependent manner. In ovarian cancer, prevalent mono-allelic deletion of BECN1...(a canonical auto...

    Authors: Rohann J. M. Correa, Yudith Ramos Valdes, Trevor G. Shepherd and Gabriel E. DiMattia
    Citation: Journal of Ovarian Research 2015 8:52
    Content type: Research Published on:

  27. Ovarian cancer is the leading cause of death for gynecological cancers and the 6th cause of women cancer death in developed countries. The late stage ... alternative treatments to improve the management of ovaria...

    Authors: Benoît Thibault and Bertrand Jean-Claude
    Citation: Journal of Ovarian Research 2017 10:31
    Content type: Research Published on:

  28. The ST6Gal-I glycosyltransferase, which adds α2–6-linked sialic acids to N...-glycosylated proteins is upregulated in a wide range of malignancies including ovarian cancer. Prior studies have shown that ST6Gal-I ...

    Authors: Kaitlyn A. Dorsett, Robert B. Jones, Katherine E. Ankenbauer, Anita B. Hjelmeland and Susan L. Bellis
    Citation: Journal of Ovarian Research 2019 12:93
    Content type: Research Published on:

  29. Ovarian cancer (OC) is one of the most ... death rate (50–60%) in ovarian cancer patients. Particularly, among newly occurred ovarian cancer patients, 70% of clinical cases are...

    Authors: Lei Zhang, Min Luo, Hongying Yang, Shaoyan Zhu, Xianliang Cheng and Chen Qing
    Citation: Journal of Ovarian Research 2019 12:19
    Content type: Research Published on:

  31. Serous epithelial ovarian cancer (SEOC) is a highly metastatic disease...

    Authors: Fateen Farhana Ibrahim, Rahman Jamal, Saiful Effendi Syafruddin, Nurul Syakima Ab Mutalib, Sazuita Saidin, Reena Rahayu MdZin, Mohammad Manir Hossain Mollah and Norfilza Mohd Mokhtar
    Citation: Journal of Ovarian Research 2015 8:56
    Content type: Research Published on:

  32. Breast cancer is the most common cancer in young women. Fortunately current survival rates ... used as a surrogate marker of infertility in cancer patients but more reliable ovarian reserve (OR ... in a cohort of...

    Authors: Cristina Silva, Ana Cristina Ribeiro Rama, Sérgio Reis Soares, Mariana Moura-Ramos and Teresa Almeida-Santos
    Citation: Journal of Ovarian Research 2019 12:102
    Content type: Research Published on:

  33. A major hurdle incurrent to the human clinical application of conditionally replicative adenovirus (CRAd)-based virotherapy agents is their limited therapeutic efficacy. In this study we evaluated whether arming ...

    Authors: Ahmad Mohammad Ashshi, Adel Galal El-Shemi, Igor P. Dmitriev, Elena A. Kashentseva and David T. Curiel
    Citation: Journal of Ovarian Research 2016 9:38
    Content type: Research Published on:

  34. Epithelial ovarian cancer (EOC) remains the most lethal gynecological cancer in developed countries, indicating the need for further research. Although current cancer models prove useful, they have major limitati...

    Authors: Sander Dumont, Ziga Jan, Ruben Heremans, Toon Van Gorp, Ignace Vergote and Dirk Timmerman
    Citation: Journal of Ovarian Research 2019 12:105
    Content type: Review Published on:

  35. Mesenchymal stem cells (MSCs) have surfaced as ideal candidates for treatment of different therapeutically challenging diseases however their effect on cancer cells is not well determined. In this ... cord derive...

    Authors: C. Khalil, M. Moussa, A. Azar, J. Tawk, J. Habbouche, R. Salameh, A. Ibrahim and N Alaaeddine
    Citation: Journal of Ovarian Research 2019 12:70
    Content type: Research Published on:

  36. Chemokines are involved in the homing of various cancer cells, including those of ovarian cancer (OvCa), to distant organs. They may also promote or inhibit cancer progression and metastasis. Hypoxia, a common...

    Authors: Santosh Kumar Singh, Manoj Kumar Mishra and Rajesh Singh
    Citation: Journal of Ovarian Research 2019 12:42
    Content type: Research Published on:

  37. Resistance to platinum-based chemotherapy remains a great challenge for ovarian cancer treatment. The human let-7 family contains ... implicated in the modulation of drug sensitivity in cancers. Our previous stud...

    Authors: Man Xiao, Jing Cai, Liqiong Cai, Jinghui Jia, Lisha Xie, Ying Zhu, Bangxing Huang, Dongdong Jin and Zehua Wang
    Citation: Journal of Ovarian Research 2017 10:24
    Content type: Research Published on:

  38. Deficiency in Vitamin D3 (cholecalciferol) may predispose to some malignancies, including gonadal tumors and in experimental models vitamin D3 has been proven to inhibit the growth of cancer cells. To learn more ...

    Authors: Ahmed Abdelbaset-Ismail, Daniel Pedziwiatr, Ewa Suszyńska, Sylwia Sluczanowska-Glabowska, Gabriela Schneider, Sham S. Kakar and Mariusz Z. Ratajczak
    Citation: Journal of Ovarian Research 2016 9:26
    Content type: Research Published on:

  39. Resveratrol exerts inhibitory effects on ovarian cancer cells, while its underlying mechanism and critical ... Notch and STAT3 signaling are frequent in ovarian cancers/OCs and supposed to be important for...

    Authors: Li-Xia Zhong, Hong Li, Mo-Li Wu, Xiao-Yu Liu, Ming-Jun Zhong, Xiao-Yan Chen, Jia Liu and Yang Zhang
    Citation: Journal of Ovarian Research 2015 8:25
    Content type: Research Published on:

  40. Ovarian cancer is the most fatal of gynaecological malignancies, ... the histopathological and molecular features of human ovarian cancer for drug-efficacy analysis.

    Authors: Natividad Gomez-Roman, Fiona McGregor, Nial J. Wheate and Jane A. Plumb
    Citation: Journal of Ovarian Research 2015 8:62
    Content type: Research Published on:

  41. The limitation of current biomarker of early stage ovarian cancer and the anatomical location of ovarian (depths of the pelvic) make ovarian cancer difficult to be detected in early stage. ... about the protein a...

    Authors: Lin Cheng, Kun Zhang, Yunan Qing, Dong Li, Manhua Cui, Peng Jin and Tianmin Xu
    Citation: Journal of Ovarian Research 2020 13:9
    Content type: Research Published on:

  43. Key features of advanced ovarian cancer include metastasis via cell clusters in the ... acetyl-resveratrol on 3D cell aggregates of ovarian cancer, and establish if NF-κB signalling may...

    Authors: Alexandria B. Tino, Kenny Chitcholtan, Peter H. Sykes and Ashley Garrill
    Citation: Journal of Ovarian Research 2016 9:84
    Content type: Research Published on:

  45. In order to validate if the test result of the Chemotherapy Resistance Test (CTR-Test) is able to predict the resistances or sensitivities of tumors in ovarian cancer patients to drugs, the CTR-Test result...

    Authors: Frank Christian Kischkel, Carina Meyer, Julia Eich, Mani Nassir, Monika Mentze, Ioana Braicu, Annette Kopp-Schneider and Jalid Sehouli
    Citation: Journal of Ovarian Research 2017 10:72
    Content type: Research Published on:

  46. Acquisition of metabolic alterations has been shown to be essential for the unremitting growth of cancer, yet the relation of such alterations to ... are specifically associated with platinum resistance in ovaria...

    Authors: Laila M Poisson, Adnan Munkarah, Hala Madi, Indrani Datta, Sharon Hensley-Alford, Calvin Tebbe, Thomas Buekers, Shailendra Giri and Ramandeep Rattan
    Citation: Journal of Ovarian Research 2015 8:13
    Content type: Research Published on:

  47. Ovarian cancer is the most lethal gynecologic malignancy characterized ... whether TQ enhances cisplatin cytotoxicity in cultured ovarian cancer cells and in an established murine syngeneic model of ovarian cancer

    Authors: Andrew J. Wilson, Jeanette Saskowski, Whitney Barham, Fiona Yull and Dineo Khabele
    Citation: Journal of Ovarian Research 2015 8:46
    Content type: Research Published on:

  48. KLK10 exon 3 hypermethylation correlated to tumor-specific lack of KLK10 expression in cancer cell lines and primary tumors. In the...KLK10 exon 3 methylation in ovarian tumor diagnosis and prognosis.

    Authors: Mustafa A. El Sherbini, Amal A. Mansour, Maha M. Sallam, Emtiaz A. Shaban, Zeinab A. Shehab ElDin and Amr H. El-Shalakany
    Citation: Journal of Ovarian Research 2018 11:32
    Content type: Research Published on:

  49. In previous studies it has been found that in cell cultures of human adult ovaries there is a population of small stem cells with diameters of 2–4 μm, which are present mainly in the ovarian surface epithelium an...

    Authors: Irma Virant-Klun, Natasa Kenda-Suster and Spela Smrkolj
    Citation: Journal of Ovarian Research 2016 9:12
    Content type: Research Published on:

  50. Epithelial ovarian cancer (EOC) is the deadliest female malignancy. ... β-catenin, has been reported in ovarian cancer. Specifically, mutations of CTNNB1, AXIN, or APC,...have been observed in the endometrioid an...

    Authors: Vu Hong Loan Nguyen, Rebecca Hough, Stefanie Bernaudo and Chun Peng
    Citation: Journal of Ovarian Research 2019 12:122
    Content type: Review Published on:
Submit manuscript

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    1,114,260 downloads
    475 Altmetric mentions

Editor News

New Content ItemEditor-in-Chief Dr Ben Tsang has been recognised by the Canadian Parliament for significant contributions to science. Please join us in celebrating this amazing achievement.

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.

Journal of Ovarian Research

ISSN: 1757-2215

Contact us